O
Oramed Pharmaceuticals Inc. (ORMP)
NCM – Real vaqt narxi. Valyuta: USD
4.45
-0.17 (-3.68%)
Yopilishda: May 12, 2026, 4:00 PM EDT
4.40
-0.05 (-1.12%)
Bozordan keyin: May 12, 2026, 7:18 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
4.45
-0.17 (-3.68%)
Yopilishda: May 12, 2026, 4:00 PM EDT
4.40
-0.05 (-1.12%)
Bozordan keyin: May 12, 2026, 7:18 PM EDT
Oramed Pharmaceuticals Inc. dorilar uchun tadqiqot va ishlanmalar bilan shug'ullanadi, terapevtik oqsillarni og'iz orqali yuborish uchun texnologik platformaga ega. Kompaniya ORMD-0801ni ishlab chiqmoqda, bu insulin kapsulasi bo'lib, u diabetga chalingan bemorlarni davolash uchun III fazali klinik sinovlardan o'tmoqda. Kompaniya COVID-19 uchun og'iz orqali yuboriladigan vaktsinalarni tijoratlashtirish bo'yicha Oravax Medical Inc. bilan litsenziya shartnomalariga ega. Oramed Pharmaceuticals Inc. 2002 yilda tashkil etilgan va uning bosh qarorgohi Nyu-York, Nyu-Yorkda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Miriam Kidron Ph.D. | Chief Scientific Officer & Director |
| Mr. Avraham Gabay | CFO, Treasurer & Secretary |
| Mr. Joshua Hexter | Chief Operating & Business Officer |
| Mr. Nadav Kidron Esq. | President, CEO & Executive Chairman |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-31 | 8-K | ea0284244-8k_oramed.htm |
| 2026-03-26 | 10-K | ea0282618-10k_oramed.htm |
| 2026-02-20 | 8-K | ormp-20260219.htm |
| 2026-01-14 | 8-K | ea0272889-8k_oramed.htm |
| 2026-01-07 | 8-K | ea0271929-8k_oramed.htm |
| 2025-12-31 | 8-K | ea0271432-8k_oramed.htm |
| 2025-11-17 | 8-A12B | ea0265959-8a12b_oramed.htm |
| 2025-11-13 | 10-Q | ea0264871-10q_oramed.htm |
| 2025-10-24 | 8-K | ea0262319-8k_oramed.htm |
| 2025-10-06 | 8-K | ea0260371-8k_oramed.htm |